Fig. 2.

Contributions from studies at high, moderate or low risk of bias to RR to prevent any mood episodes. ARP aripiprazole, CBZ carbamazepine, FLX fluoxetine, IMP imipramine, LIT lithium, LTG lamotrigine, OLZ olanzapine, OXC oxcarbazepine, PAL paliperidone, PLB placebo, QTP quetiapine, RisLAI risperidone long-acting injection, VPA valproate (Figure dapted from p. 98 of the Appendix in Miura et al. [4])